Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This year tags : Covid save search
Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment
Published: 2024-02-21 (Crawled : 19:00) - biospace.com/
LGST | $4.51 -11.31% 13K
|
n/a
| Email alert
Add to watchlist
covid company genetic cell treatment potential therapy study
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
NNVC | $1.175 1.29% 0.0% 13K
|
Health Technology
|
| O: 2.56%
H: 0.83%
C: -0.83%
nv-387 covid report treatment trial
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 2.0%
H: 1.15%
C: -0.37%
covid risk pharmaceuticals research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.